171 related articles for article (PubMed ID: 37554427)
1. NMR indicates the N-termini of PSGL1 and CCR7 bind competitively to the chemokine CCL21.
Witt RN; Nickel KS; Binns JR; Gray AM; Hintz AM; Kofron NF; Steigleder SF; Peterson FC; Veldkamp CT
Biochem Biophys Rep; 2023 Sep; 35():101524. PubMed ID: 37554427
[TBL] [Abstract][Full Text] [Related]
2. CCR7 Sulfotyrosine Enhances CCL21 Binding.
Phillips AJ; Taleski D; Koplinski CA; Getschman AE; Moussouras NA; Richard AM; Peterson FC; Dwinell MB; Volkman BF; Payne RJ; Veldkamp CT
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28841151
[TBL] [Abstract][Full Text] [Related]
3. Selective Boosting of CCR7-Acting Chemokines; Short Peptides Boost Chemokines with Short Basic Tails, Longer Peptides Boost Chemokines with Long Basic Tails.
Brandum EP; Jørgensen AS; Calvo MB; Spiess K; Peterson FC; Yang Z; Volkman BF; Veldkamp CT; Rosenkilde MM; Goth CK; Hjortø GM
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163323
[TBL] [Abstract][Full Text] [Related]
4. Solution structure of CCL21 and identification of a putative CCR7 binding site.
Love M; Sandberg JL; Ziarek JJ; Gerarden KP; Rode RR; Jensen DR; McCaslin DR; Peterson FC; Veldkamp CT
Biochemistry; 2012 Jan; 51(3):733-5. PubMed ID: 22221265
[TBL] [Abstract][Full Text] [Related]
5. The C-terminal peptide of CCL21 drastically augments CCL21 activity through the dendritic cell lymph node homing receptor CCR7 by interaction with the receptor N-terminus.
Jørgensen AS; Brandum EP; Mikkelsen JM; Orfin KA; Boilesen DR; Egerod KL; Moussouras NA; Vilhardt F; Kalinski P; Basse P; Chen YH; Yang Z; Dwinell MB; Volkman BF; Veldkamp CT; Holst PJ; Lahl K; Goth CK; Rosenkilde MM; Hjortø GM
Cell Mol Life Sci; 2021 Nov; 78(21-22):6963-6978. PubMed ID: 34586443
[TBL] [Abstract][Full Text] [Related]
6. Common and biased signaling pathways of the chemokine receptor CCR7 elicited by its ligands CCL19 and CCL21 in leukocytes.
Hauser MA; Legler DF
J Leukoc Biol; 2016 Jun; 99(6):869-82. PubMed ID: 26729814
[TBL] [Abstract][Full Text] [Related]
7. CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway.
Zhang L; Wang D; Li Y; Liu Y; Xie X; Wu Y; Zhou Y; Ren J; Zhang J; Zhu H; Su Z
PLoS One; 2016; 11(8):e0158529. PubMed ID: 27505247
[TBL] [Abstract][Full Text] [Related]
8. Heparin Specifically Interacts with Basic BBXB Motifs of the Chemokine CCL21 to Define CCR7 Signaling.
Artinger M; Gerken OJ; Legler DF
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675182
[TBL] [Abstract][Full Text] [Related]
9. Biased signaling of G protein-coupled receptors - From a chemokine receptor CCR7 perspective.
Jørgensen AS; Rosenkilde MM; Hjortø GM
Gen Comp Endocrinol; 2018 Mar; 258():4-14. PubMed ID: 28694053
[TBL] [Abstract][Full Text] [Related]
10. Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7.
Jørgensen AS; Larsen O; Uetz-von Allmen E; Lückmann M; Legler DF; Frimurer TM; Veldkamp CT; Hjortø GM; Rosenkilde MM
Front Immunol; 2019; 10():2156. PubMed ID: 31572374
[TBL] [Abstract][Full Text] [Related]
11. Fluorescently Tagged CCL19 and CCL21 to Monitor CCR7 and ACKR4 Functions.
Purvanov V; Matti C; Samson GPB; Kindinger I; Legler DF
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30518137
[TBL] [Abstract][Full Text] [Related]
12. CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells.
Takeuchi H; Fujimoto A; Tanaka M; Yamano T; Hsueh E; Hoon DS
Clin Cancer Res; 2004 Apr; 10(7):2351-8. PubMed ID: 15073111
[TBL] [Abstract][Full Text] [Related]
13. Distinct CCR7 glycosylation pattern shapes receptor signaling and endocytosis to modulate chemotactic responses.
Hauser MA; Kindinger I; Laufer JM; Späte AK; Bucher D; Vanes SL; Krueger WA; Wittmann V; Legler DF
J Leukoc Biol; 2016 Jun; 99(6):993-1007. PubMed ID: 26819318
[TBL] [Abstract][Full Text] [Related]
14. CCL21/CCR7 axis as a therapeutic target for autoimmune diseases.
Han L; Zhang L
Int Immunopharmacol; 2023 Aug; 121():110431. PubMed ID: 37331295
[TBL] [Abstract][Full Text] [Related]
15. CXCL12 promotes CCR7 ligand-mediated breast cancer cell invasion and migration toward lymphatic vessels.
Hayasaka H; Yoshida J; Kuroda Y; Nishiguchi A; Matsusaki M; Kishimoto K; Nishimura H; Okada M; Shimomura Y; Kobayashi D; Shimazu Y; Taya Y; Akashi M; Miyasaka M
Cancer Sci; 2022 Apr; 113(4):1338-1351. PubMed ID: 35133060
[TBL] [Abstract][Full Text] [Related]
16. Chemokine (C‑C motif) ligand 21/C‑C chemokine receptor type 7 triggers migration and invasion of human lung cancer cells by epithelial‑mesenchymal transition via the extracellular signal‑regulated kinase signaling pathway.
Zhong G; Chen L; Yin R; Qu Y; Bao Y; Xiao Q; Zhang Z; Shen Y; Li C; Xu Y; Zou Z; Tian H
Mol Med Rep; 2017 Jun; 15(6):4100-4108. PubMed ID: 28487957
[TBL] [Abstract][Full Text] [Related]
17. CCL21 promotes the migration and adhesion of highly lymph node metastatic human non-small cell lung cancer Lu-99 in vitro.
Koizumi K; Kozawa Y; Ohashi Y; Nakamura ES; Aozuka Y; Sakurai H; Ichiki K; Doki Y; Misaki T; Saiki I
Oncol Rep; 2007 Jun; 17(6):1511-6. PubMed ID: 17487412
[TBL] [Abstract][Full Text] [Related]
18. Expression of chemokine receptor CCR7 is associated with cervical lymph node metastasis of oral squamous cell carcinoma.
Shang ZJ; Liu K; Shao Z
Oral Oncol; 2009 Jun; 45(6):480-5. PubMed ID: 18752985
[TBL] [Abstract][Full Text] [Related]
19. Tumor hypoxia modulates podoplanin/CCL21 interactions in CCR7+ NK cell recruitment and CCR7+ tumor cell mobilization.
Tejchman A; Lamerant-Fayel N; Jacquinet JC; Bielawska-Pohl A; Mleczko-Sanecka K; Grillon C; Chouaib S; Ugorski M; Kieda C
Oncotarget; 2017 May; 8(19):31876-31887. PubMed ID: 28416768
[TBL] [Abstract][Full Text] [Related]
20. Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemia.
Cuesta-Mateos C; López-Giral S; Alfonso-Pérez M; de Soria VG; Loscertales J; Guasch-Vidal S; Beltrán AE; Zapata JM; Muñoz-Calleja C
Exp Hematol; 2010 Sep; 38(9):756-64, 764.e1-4. PubMed ID: 20488224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
